MS Pharma Establishes MENA's First Biologics Manufacturing Hub in Saudi Arabia, Advancing Regional Leadership and Global Partnerships

MS Pharma Saudi Arabia France Germany United Kingdom United States of America Austria Switzerland Belgium Italy Netherlands Spain Lebanon Saudi Arabia Qatar Yemen Jordan Kuwait Oman Morocco Iran Egypt

MS Pharma inaugurates Middle East's first biologics manufacturing facility in Saudi Arabia, SFDA-approved and built to meet EMA and FDA standards.Specialized in monoclonal antibodies and complex peptides, with in-house bioanalytical labs.Strategic platform for global partners, enabling localized and contract manufacturing access to MENA, EU, and US markets.View original content:https://www.prnewswire.co.uk/news-releases/ms-pharma-establishes-menas-first-biologics-manufacturing-hub-in-saudi-arabia-advancing-regional-leadership-and-global-partnerships-302539994.html